Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the short-term and long-term efficacies and the
safeties of pirarubicin plus docetaxel(AT group) and pirarubicin plus cyclophosphamide
followed by docetaxel(AC-T group) in neoadjuvant chemotherapy of breast cancer.